
|Articles|January 23, 2019
Dissolution and the USP Performance Verification Test
Author(s)USP
Trending on Pharmaceutical Technology
1
The FDA Moves to Modernize Drug Manufacturing Registration
2
PharmTech Weekly Roundup–July 10, 2026
3
What the Ocrelizumab Deal Does for the Multiple Sclerosis Biosimilar Pipeline
4
The Implications of Isatuximab-irfc’s FDA Approval for Multiple Myeloma
5



